Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study
- PMID: 23137820
- PMCID: PMC3493986
- DOI: 10.1136/bmj.e7085
Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study
Abstract
Objective: To investigate the risks of adverse pregnancy and birth outcomes for treated and untreated bipolar disorder during pregnancy.
Design: Population based cohort study using data from national health registers.
Setting: Sweden.
Participants: 332,137 women with a last menstrual period anytime after 1 July 2005 and giving birth anytime before the end of 31 December 2009. Women with a record of at least two bipolar diagnoses were identified and grouped as treated (n = 320)-those who had filled a prescription for mood stabilisers (lithium, antipsychotics, or anticonvulsants) during pregnancy-or untreated (n = 554). Both groups were compared with all other women giving birth (n = 331,263).
Main outcome measures: Preterm birth, mode of labour initiation, gestational diabetes, infants born small or large for gestational age, neonatal morbidity, and congenital malformations.
Results: Of the untreated women, 30.9% (n = 171) were induced or had a planned caesarean delivery compared with 20.7% (n = 68,533) without bipolar disorder (odds ratio 1.57, 95% confidence interval 1.30 to 1.90). The corresponding values for the treated women were 37.5% (n = 120) (2.12, 1.68 to 2.67). The risks of preterm birth in both treated and untreated women were increased by 50%. Of the untreated women, 3.9% (n = 542) had a microcephalic infant compared with 2.3% (324,844) of the women without bipolar disorder (1.68, 1.07 to 2.62). The corresponding values for the treated women were 3.3% (n = 311) (1.26, 0.67 to 2.37). Similar trends were observed for risks of infants being small for gestational age infants for weight and length. Among infants of untreated women, 4.3% (n = 24) had neonatal hypoglycaemia compared with 2.5% (n=8302) among infants of women without bipolar disorder (1.51, 1.04 to 2.43), and 3.4% (n = 11) of the treated women (1.18, 0.64 to 2.16). The analyses of variation in outcomes did not support any significant differences between treated and untreated women.
Conclusions: Bipolar disorder in women during pregnancy, whether treated or not, was associated with increased risks of adverse pregnancy outcomes.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at
Comment in
-
Bipolar disorder in pregnancy: to treat or not to treat?BMJ. 2012 Nov 9;345:e7367. doi: 10.1136/bmj.e7367. BMJ. 2012. PMID: 23144175 No abstract available.
Similar articles
-
Risk of adverse pregnancy, delivery and neonatal outcomes associated with bipolar disorder and prenatal use of mood stabilizers: A population-based cohort study.Psychiatry Res. 2024 Sep;339:116050. doi: 10.1016/j.psychres.2024.116050. Epub 2024 Jun 21. Psychiatry Res. 2024. PMID: 38914040
-
Perinatal outcomes among women with bipolar disorder: a population-based cohort study.Am J Obstet Gynecol. 2015 Mar;212(3):367.e1-8. doi: 10.1016/j.ajog.2014.10.020. Epub 2014 Oct 15. Am J Obstet Gynecol. 2015. PMID: 25446660
-
Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age.JAMA Intern Med. 2021 Oct 1;181(10):1332-1340. doi: 10.1001/jamainternmed.2021.4571. JAMA Intern Med. 2021. PMID: 34398171 Free PMC article.
-
Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records.Health Technol Assess. 2016 Mar;20(23):1-176. doi: 10.3310/hta20230. Health Technol Assess. 2016. PMID: 27029490 Free PMC article. Review.
-
Celiac disease and obstetric complications: a systematic review and metaanalysis.Am J Obstet Gynecol. 2016 Feb;214(2):225-234. doi: 10.1016/j.ajog.2015.09.080. Epub 2015 Oct 9. Am J Obstet Gynecol. 2016. PMID: 26432464 Review.
Cited by
-
Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes.CNS Drugs. 2024 Nov 11. doi: 10.1007/s40263-024-01131-x. Online ahead of print. CNS Drugs. 2024. PMID: 39528870
-
Obstetric Outcomes in Women on Lithium: A Systematic Review and Meta-Analysis.J Clin Med. 2024 Aug 18;13(16):4872. doi: 10.3390/jcm13164872. J Clin Med. 2024. PMID: 39201016 Free PMC article. Review.
-
Lithium Ions as Modulators of Complex Biological Processes: The Conundrum of Multiple Targets, Responsiveness and Non-Responsiveness, and the Potential to Prevent or Correct Dysregulation of Systems during Aging and in Disease.Biomolecules. 2024 Jul 25;14(8):905. doi: 10.3390/biom14080905. Biomolecules. 2024. PMID: 39199293 Free PMC article. Review.
-
High lithium concentration at delivery is a potential risk factor for adverse outcomes in breastfed infants: a retrospective cohort study.Int J Bipolar Disord. 2023 Nov 30;11(1):36. doi: 10.1186/s40345-023-00317-4. Int J Bipolar Disord. 2023. PMID: 38032417 Free PMC article.
-
Prevalence of preterm birth in Scandinavian countries: a systematic review and meta-analysis.J Int Med Res. 2023 Oct;51(10):3000605231203843. doi: 10.1177/03000605231203843. J Int Med Res. 2023. PMID: 37843530 Free PMC article.
References
-
- Müller-Oerlinghausen B, Berghöfer A, Bauer M. Bipolar disorder. Lancet 2002;359:241-7. - PubMed
-
- Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O’Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009;11:225-55. - PubMed
-
- Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004;161:608-20. - PubMed
-
- Lin HC, Chen IJ, Chen YH, Lee HC, Wu FJ. Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res 2010;116:55-60. - PubMed
-
- Newham JJ, Thomas SH, MacRitchie K, McElhatton PR, McAllister-Williams RH. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry 2008;192:333-7. - PubMed